news
‘Seismic changes’ coming to the osteoarthritis treatment market
24 February 2016 | By Victoria White
The osteoarthritis treatment market will experience seismic changes over the next decade, according to a GlobalData analyst...
List view / Grid view
Drug Markets
news
China to remain the largest hepatitis B market, says GlobalData
24 February 2016 | By Victoria White
GlobalData says China will continue to dominate the hepatitis B treatment space, as its market share rises from 38.8% in 2014 to 47.2% by 2024...
news
Zepatier to threaten the dominance of Harvoni in the HCV market
15 February 2016 | By Victoria White
A GlobalData analyst says that the combination of Zepatier’s excellent clinical profile and highly competitive pricing will play a major role in encouraging its uptake...
news
ADHD drug Adzenys addresses unmet need for patients, says GlobalData
12 February 2016 | By Victoria White
The recent FDA approval of Adzenys will provide patients who have problems swallowing pills with easy-to-administer drug options, according to GlobalData analyst...
news
Gilotrif to gain ground in the NSCLC treatment markets outside the US
9 February 2016 | By Victoria White
An analyst from GlobalData says promising clinical trial data for Gilotrif (afatinib) will strengthen the drug’s position in NSCLC treatment markets outside the US...
news
Head and neck cancer treatment market to reach $1.53b by 2024
3 February 2016 | By Victoria White
GlobalData says the treatment market for head and neck cancer will expand almost fourfold from $386 million in 2014 to $1.53 billion...
news
Incentives and collaborations required to tackle superbugs, says GlobalData
2 February 2016 | By GlobalData
A GlobalData analyst says increased collaboration and further financial incentives are required to fight the mounting threat posed by superbugs...
news
B-cell NHL treatment market to reach $5.45 billion by 2024, says GlobalData
28 January 2016 | By Victoria White
GlobalData states that the limited growth in the B-cell NHL treatment market will be hindered by the entry of biosimilars and generics combined with a weak pipeline...
news
Cosentyx to achieve blockbuster status
27 January 2016 | By Victoria White
Alexandra Annis states that Cosentyx's latest approval will bring exciting new treatment options to US patients dissatisfied with current therapies...
news
SCLC treatment market value to rise to $2.29b by 2024, says GlobalData
22 January 2016 | By Victoria White
GlobalData states that the impressive growth will primarily be driven by the launch of premium-priced therapies, including anti-PD-1 and anti-CTLA-4 immunotherapies and targeted agents...
news
Pulmonary arterial hypertension treatment market to experience modest growth
21 January 2016 | By Victoria White
The pulmonary arterial hypertension treatment market will grow from $3.45 billion in 2014 to $4.75 billion by 2024, according to research and consulting firm GlobalData...
news
Hepatitis B therapeutics market to rise to $3b by 2024, says GlobalData
20 January 2016 | By Victoria White
GlobalData says the expansion will be slight due to the patent expiration of all existing branded drugs in the chronic hepatitis B therapeutics space during the forecast period, and continued low diagnosis and treatment rates of the disease...
news
Hodgkin’s lymphoma treatment market to hit $1.4b by 2024, says GlobalData
19 January 2016 | By Victoria White
GlobalData says the impressive growth in the market will be attributable to label extensions for Seattle Genetics’ Adcetris and the launch of new therapies for relapse or refractory Hodgkin’s lymphoma...
news
Bladder cancer treatment market set to boom, says GlobalData
14 January 2016 | By Victoria White
The company states that the growth will be primarily down to the introduction of Telesta Therapeutics MCNA and Roche’s atezolizumab in 2016 and Bristol-Myers Squibb’s Opdivoin 2017...
news
RSV treatment market to expand at ‘unprecedented levels’
13 January 2016 | By Victoria White
The RSV treatment market will rise from approximately $640 million in 2014 to over $2.3 billion by 2024, says research and consulting firm GlobalData...
